Lung cancer screening in never smokers

2024-9-10

The 5T's of health disparities in multiple myeloma in Latin America

2024-9-9

Perioperative immunotherapy in nonsmall cell lung cancer

2024-9-6

Achievements of international rare cancers networks and consortia in the neuro-oncology field

2024-8-29

Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments

2024-8-27

PARP inhibitor resistant BRCA-mutated advanced breast cancer: current landscape and emerging treatments

2024-8-23

Duodenal-type follicular lymphoma: comprehensive insights into disease characteristics and established treatment strategies

2024-8-23

When do I ask for a DNA methylation array for primary brain tumor diagnosis?

2024-8-23

Biomarker-directed therapy in multiple myeloma

2024-8-23

The emerging role of melflufen and peptide-conjugates in multiple myeloma

2024-8-22

Endocrine therapy for early breast cancer in the era of oral selective estrogen receptor degraders: challenges and future perspectives

2024-8-13

Immunotherapy in first line treatment of adult acute lymphoblastic leukemia

2024-8-13

Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials

2024-8-8

Impact of sentinel node implementation in gynecologic cancers

2024-8-8

Editorial introductions

2024-8-6

Antibody-drug conjugates in metastatic breast cancer: sequencing, combinations and resistances

2024-8-6

Genomic tests for risk stratification in patients with early human epidermal growth factor receptor 2-positive breast cancer

2024-7-25

Role of sentinel lymph node biopsy with indocyanine green and site of injection in endometrial cancer

2024-7-18

Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine

2024-7-16

Chimeric antigen receptor adoptive immunotherapy in central nervous system tumors: state of the art on clinical trials, challenges, and emerging strategies to addressing them

2024-7-11

Liquid biopsy in brain tumors: moving on, slowly

2024-7-11

How to treat localized Hodgkin lymphoma?

2024-7-5

Patient-reported outcomes in neuro-oncology

2024-7-5

RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice

2024-7-5

Update of antibody–drug conjugates for hematological malignancies

2024-7-1

How to treat advanced Hodgkin lymphoma?

2024-6-26

Survivorship after Hodgkin lymphoma and the right to be forgotten

2024-6-25

Potential application of artificial intelligence in cancer therapy

2024-6-25

What is the best salvage therapy for Hodgkin lymphoma?

2024-6-21

Treatment approaches for older Hodgkin lymphoma patients

2024-6-21

Antibody-drug conjugates in solid tumors: a new frontier

2024-6-20

The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies

2024-6-20

Different tracers for sentinel node detection in gynecologic oncology

2024-6-20

Impact of sentinel node use in lymphedema formation among gynecologic cancer patients

2024-6-18

The evolution of molecular management of carcinoma of unknown primary

2024-6-18

Implementation of sentinel node biopsy in high-risk endometrial cancer

2024-6-13

Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives

2024-6-13

Value of sentinel node ultrastaging and pathologic techniques in tumoral detection

2024-6-13

Benefits of sentinel node detection in cervical cancer

2024-6-13

Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification

2024-6-13

Future of sentinel node biopsy in ovarian cancer

2024-6-12

Editorial introductions

2024-6-6

Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making

2024-6-6

Health education in cancer patients: a renewed paradigm of “active” prevention

2024-6-6

Emerging therapies in Ewing sarcoma

2024-5-22

Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials

2024-5-9

Active surveillance and emerging medical treatment options for desmoid: when and for whom?

2024-5-7

State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies

2024-5-7

New targeted therapies in liposarcoma: state of art and future perspectives

2024-5-7

State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies

2024-5-1